Skip to content

Hemophagocytic Lymphohistiocytosis Familial 6 C5436563

Published: July 22, 2026Updated: August 20, 2026

This is a genetic form of HLH caused by mutations affecting immune cell function. It presents with severe immune dysregulation in early life. Treatment involves immunosuppressive therapy and stem cell transplantation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D76.1
ICD-11
3A00.0
Body system
immunologic
Severity
critical
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

!

Encephalopathy

Fever

(Immunologic)

Hepatosplenomegaly

(Hematologic)

Pancytopenia

(Hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

HLH-2004 Protocol Chemotherapy

Aggressive induction chemotherapy using dexamethasone, etoposide, and cyclosporine adapted from the HLH-2004 treatment regimen for familial HLH forms.

medication
2

Outpatient procedure with monitoring

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
3

Hematopoietic Stem Cell Transplantation

The only curative treatment for familial HLH-6, providing permanent immune reconstitution through transplantation of healthy donor stem cells.

surgical

Additional treatment options

Anti-Thymocyte Globulin-Based Intensification

Rabbit ATG therapy for patients with inadequate response to initial chemotherapy, providing profound T-cell depletion to control disease activity.

medication

Frequent Laboratory and Clinical Surveillance

Serial monitoring of HLH biomarkers including ferritin, soluble IL-2 receptor, and natural killer cell function along with organ-specific assessments.

monitoring

Therapeutic Plasma Exchange

Apheresis procedure to remove circulating inflammatory cytokines and replenish deficient plasma factors in patients with severe refractory disease.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Hemophagocytic Lymphohistiocytosis Familial 6 C5436563?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007.

guideline2007
2

Canna SW, Behrens EM. Making sense of the heterogeneity of hemophagocytic lymphohistiocytosis. Crit Rev Immunol. 2012.

review2012
3

Bergsten E, Horne A, Hed Myrberg I, et al. Stem cell transplantation for familial hemophagocytic lymphohistiocytosis type 2: a prospective clinical trial. Blood. 2020.

clinical_trial2020
4

Marsh RA, Jordan MB, Filipovich AH. Reduced-intensity hematopoietic cell transplantation for familial hemophagocytic lymphohistiocytosis: a systematic review and meta-analysis. Biol Blood Marrow Transplant. 2021.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Hemophagocytic Lymphohistiocytosis Familial 6 C5436563. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy